DESCRIPTION

In this interview for the JCI series Conversations with Giants in Medicine, Ushma Neill speaks with the biochemist Roy Vagelos, who is best known for leading Merck for 20 years, first as president of research, and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way they approached drug discovery, introduced the first statins to market, and organized the donation of ivermectin, the agent for control of river blindness, to any and all who need it, for as long as it is needed.